logo inner

VP, FP&A

CareDxBrisbane, Australia | California, United StatesOnsite
This job is no longer open

CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services, and digital healthcare solutions along the pre-and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
CareDX is seeking an FP&A VP to join their high-performing organization. The Global FP&A team partners closely with the company’s business leaders to drive business results, financial insights, budgeting, forecasting, and accelerate the modernization of the company’s financial reporting infrastructure. In addition, the Finance team is tasked with managing the treasury function that includes appropriate investments and insights on Cash and Cash flows given the large cash balance.

WHAT YOU’LL DO


  • Be a thought leader and partner with executive leadership to provide business analytics and insights to drive business results.
  • Manage and oversee annual budgeting, forecasting, Reporting and long-range financial planning processes.
  • Build narrative/presentation for executive leadership, board meetings and external stakeholders.
  • Work closely with CEO/CFO, help build guidance for the street, anticipate questions on quarterly results/guidance from the analysts/investors and provide necessary information to address the same
  • Drive finance discipline, fact-based decision-making, and financial visibility across the company
  • Drive dialogue between key stakeholders to establish and evolve organizational KPIs
  • Lead the finance transformation for systems/processes, use of AI in financial analysis and re-porting
  • Lead Treasury function/decision making process to protect and invest cash appropriately.
  • Collaborate with cross-functional teams to collect relevant data and insights for financial analy-sis.
  • Mentor and develop FP&A team members, promoting a culture of continuous learning and professional growth.
  • Work collaboratively with the Finance teams to support and review monthly financial reporting performance and drive timely reporting.

WHAT YOU’LL BRING


  • Minimum of 15+ years of experience in financial planning and analysis in a global high growth company.
  • 5+ years of managerial experience.
  • Advanced proficiency in financial modeling, forecasting, and data analysis.
  • Strong analytical and problem-solving skills with the ability to translate complex financial data into actionable insights.
  • Excellent communication and presentation skills, a strategic thinker
  • Proficiency in using financial planning and reporting software.
  • Ability to work independently in a fast-paced environment.
  • Versatile collaborator with exceptional work ethic, eager to learn, ask questions, and navigate across different perspectives.
  • Bachelor’s degree in Accounting, Finance, or Economics. MBA is a plus.
  • Professional certification such as CMA/CPA is a plus.

Additional Details:


Every individual at CareDx has a direct impact on our collective mission to improve the lives of organ transplant patients worldwide. We believe in taking great care of our people, so they take even greater care of our patients.Our competitive Total Rewards package includes:

  • Competitive base salary and incentive compensation
  • Health and welfare benefits including a gym reimbursement program
  • 401(k) savings plan match
  • Employee Stock Purchase Plan
  • Pre-tax commuter benefits
  • And more!

In addition, we have a Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.With products that are making a difference in the lives of transplant patients today and a promising pipeline for the future, it’s an exciting time to be part of the CareDx team. Join us in partnering with transplant patients to transform our future together.

CareDx, Inc. is an Equal Opportunity Employer and participates in the E-Verify program.


By proceeding with our application and submitting your information, you acknowledge that you have read our 


U.S. Personnel Privacy Notice


and consent to receive email communication from CareDx.


******** We do not accept resumes from headhunters, placement agencies, or other suppliers that have not signed a formal agreement with us.#LI-Hybrid

This job is no longer open

Life at CareDx

CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. NASDAQ:CDNA About AlloSure® AlloSure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. AlloSure is a clinical-grade, proprietary Next-Generation Sequencing (NGS) based test to detect donor-derived cell-free DNA (dd-cfDNA) in order to identify organ injury in kidney transplant recipients. AlloSure is analytically validated as a sensitive, specific, and precise measurement of dd-cfDNA. AlloSure detects active rejection (acute active ABMR, chronic active ABMR, or TCMR) with high accuracy, outperforms serum creatinine in kidney transplant recipients, and is highly sensitive in distinguishing ABMR from no ABMR. AlloSure is performed in the CareDx CLIA-certified laboratory. http://www.allosure.com/ About AlloMap® AlloMap Molecular Expression Testing is a non-invasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. AlloMap testing measures the expression levels of 20 genes from a blood sample. The combined expression of these genes is represented as an AlloMap test score. AlloMap is performed in the CareDx CLIA-certified laboratory and has been commercially available in the United States since 2005. AlloMap was cleared by the U.S. Food and Drug Administration in 2008 and was CE marked for the European Union in 2011. Use of AlloMap is also included in the International Society for Heart and Lung Transplantation (ISHLT) Practice Guidelines, published in August 2010, the worldwide standard for the care of heart transplant patients. http://www.allomap.com/
Thrive Here & What We Value1. Focus on improving the lives of organ transplant patients worldwide2. Taking great care of our people, so they take even greater care of our patients3. CareDx offers products, testing services, and digital healthcare solutions along the pre and post-transplant patient journey4. CareDx is the leading provider of genomics-based information for transplant patients5. Competitive Total Rewards package including: Competitive base salary and incentive compensation, Health and welfayer benefits, 401(k) savings plan match, Employee Stock Purchase Plan, Pretax commuter benefits
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2025